SpecificationsOrganism/cell line/tissueHuman Caco-2 cells (enterocytes)SexN/ASequencer or array typeμParaflo®Microfluidic Biochip Technology of LC Sciences (Huston, TX, USA)Data formatRaw dataExperimental factorsMicelles containing cholesterol, CLA or DHA vs. empty micellesExperimental featuresDifferentiated Caco-2 cells were treated with micelles containing cholesterol (48 h) or micelles containing DHA or CLA (24 h). Control cells were treated with empty micelles. miRNA-enriched total RNA was isolated with miRNeasy mini kit (Qiagen, Madrid, Spain). The expression of miRNAs contained in the miRBase version 17 was analyzed by microarray using the μParaflo®Microfluidic Biochip Technology of LC Sciences (Huston, TX, USA). Raw data were normalized, processed and analyzed for statistical significance using t-test and applying multiple testing correctionConsentN/ASample source locationN/A

1. Direct link to deposited data {#s0005}
================================

<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE59153>.

2. Experimental design, materials and methods {#s0010}
=============================================

For differentiation, Caco-2 cells were plated on polycarbonate Transwell® filter inserts of 0.4 μm pore size (Costar, Madrid, Spain) in 6-well plates. Approximately 14 days after confluence cells develop morphologic and physiologic characteristics of normal enterocytes [@bb0015]. Cholesterol (Chol), CLA and DHA (Sigma, Madrid, Spain) were delivered to cells as micelles with Lyso-phosphatidylcholine (Lyso-PC; Sigma, Madrid, Spain) and sodium taurocholate (Tau; Sigma, Madrid, Spain) [@bb0020]. Briefly, Chol (250 μM), CLA (200 μM) or DHA (200 μM) were diluted in n-hexane (Scharlab; Barcelona, Spain) and dried under a nitrogen stream. Lyso-PC (200 μM) was also diluted in n-hexane and mixed with the dried Chol, CLA or DHA, respectively. The mixture was then dried under a nitrogen stream. Tau (5 mM) was diluted in ethanol 95% and added to the Lyso-PC/lipid mixture and then evaporated under a nitrogen stream. The resulted micelles were diluted in a serum-free medium and mixed vigorously until clear. As control, we used empty micelles made with Lyso-PC and Tau. Four control and cholesterol samples, three DHA samples and two CLA samples were analyzed.

MicroRNA-enriched total RNA was isolated with miRNeasy mini kit (Qiagen, Madrid, Spain) following manufacturer\'s instructions. Total RNA concentration was quantified with a Nanodrop and the integrity was confirmed in a 1% agarose gel.

The expression of microRNAs contained in the miRBase version 17 was analyzed by microarray using the μParaflo®Microfluidic Biochip Technology of LCsciences (Huston, TX, USA). A total of 1 μg of miRNA-enriched RNA was used for miRNA microarray. At least three samples of each condition were analyzed (except for CLA, for which we processed two biological replicates). Raw data corresponding to signal intensity were corrected for background subtraction and normalized using the LOWESS (locally weighted regression) method. Relative miRNA levels were calculated as the Log2 of test intensity/control intensity. Data were processed to merge replicates and discard discordant replicates (1-fold Standard deviation). The resulting fold change (FC) was Log2 transformed and analyzed for statistical significance using t-test and applying multiple testing corrections. Microarray data has been submitted to the GEO database complying with the Minimal Information About a Microarray Experiment (MIAME) guidelines ([GSE59153](ncbi-geo:GSE59153){#ir0015}). Significant microRNAs were clustered using average linkage algorithm and Euclidean distance correlation with TigerMEV software (Boston, MA, USA) ([Fig. 1](#f0005){ref-type="fig"}).
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![Cluster analysis of differentially expressed miRNAs with cholesterol (A), CLA (B) or DHA (C) comparing with empty micelle treated cells. miRNA expression was measured by microarray and relative expression was calculated as the Log2 (test intensity/control intensity) after background subtraction and LOWESS normalization.](gr1){#f0005}
